215 related articles for article (PubMed ID: 17909835)
1. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
2. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
Cursiefen C; Maruyama K; Jackson DG; Streilein JW; Kruse FE
Cornea; 2006 May; 25(4):443-7. PubMed ID: 16670483
[TBL] [Abstract][Full Text] [Related]
3. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
[TBL] [Abstract][Full Text] [Related]
4. Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages.
Yuen D; Pytowski B; Chen L
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2593-7. PubMed ID: 21273538
[TBL] [Abstract][Full Text] [Related]
5. Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.
Shi W; Ming C; Liu J; Wang T; Gao H
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):55-67. PubMed ID: 20640436
[TBL] [Abstract][Full Text] [Related]
6. Regression of mature lymphatic vessels in the cornea by photodynamic therapy.
Bucher F; Bi Y; Gehlsen U; Hos D; Cursiefen C; Bock F
Br J Ophthalmol; 2014 Mar; 98(3):391-5. PubMed ID: 24414403
[TBL] [Abstract][Full Text] [Related]
7. Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
Fukumoto A; Maruyama K; Walsh T; Kajiya K; Hamuro J; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2450-8. PubMed ID: 20042658
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic vessels identified in failed corneal transplants with neovascularisation.
Diamond MA; Chan SWS; Zhou X; Glinka Y; Girard E; Yucel Y; Gupta N
Br J Ophthalmol; 2019 Mar; 103(3):421-427. PubMed ID: 30348644
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of Angiogenic Responses in Corneal Transplantation.
Inomata T; Mashaghi A; Di Zazzo A; Lee SM; Chiang H; Dana R
Cornea; 2017 Apr; 36(4):491-496. PubMed ID: 28060028
[TBL] [Abstract][Full Text] [Related]
10. b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.
Hajrasouliha AR; Sadrai Z; Chauhan SK; Dana R
Cornea; 2012 Jul; 31(7):804-9. PubMed ID: 22467003
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.
Rho CR; Choi JS; Seo M; Lee SK; Joo CK
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5871-9. PubMed ID: 26348636
[TBL] [Abstract][Full Text] [Related]
12. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.
Lipp M; Bucher F; Parthasarathy A; Hos D; Onderka J; Cursiefen C; Bock F
Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):943-9. PubMed ID: 24728466
[TBL] [Abstract][Full Text] [Related]
14. Corneal Collagen Cross-Linking With Riboflavin and UVA Regulates Hemangiogenesis and Lymphangiogenesis in Rats.
Zhu Y; Li L; Reinach PS; Li Y; Ge C; Qu J; Chen W
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3702-3712. PubMed ID: 30029257
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term corneal vascular effects of tafluprost eye drops.
Hos D; Koch KR; Bock F; Grajewski RS; Dietlein TS; Cursiefen C; Heindl LM
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1919-27. PubMed ID: 23624591
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
[TBL] [Abstract][Full Text] [Related]
18. Regulation of blood vessel versus lymphatic vessel growth in the cornea.
Chung ES; Saban DR; Chauhan SK; Dana R
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1613-8. PubMed ID: 19029028
[TBL] [Abstract][Full Text] [Related]
19. Label-Free In Vivo Imaging of Corneal Lymphatic Vessels Using Microscopic Optical Coherence Tomography.
Horstmann J; Schulz-Hildebrandt H; Bock F; Siebelmann S; Lankenau E; Hüttmann G; Steven P; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5880-5886. PubMed ID: 29149239
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
